NEUROSTECH has been awarded a grant to support the starting-up process. The EIBT program is meant for innovative, technology base companies starting operations. The grant to NEUROSTECH (IDE/2020/000733) is awarded by the Government of Asturias´ innovation agency (IDEPA).

The project activities granted are focused on the design of a new strategy to treat Alzheimer´s disease, specifically a combination of implantable device for intrathecal pseudo-delivery of drugs, for example an anti‑ß42 amyloid mAb.